THIS COURSE IS SOLD OUT!
When: Saturday, 29 October 2016
Where: Surrey Memorial Hospital, 13750 96 Ave, Surrey BC [map]
What: Bringing Best Evidence to Clinicians: Combining Evidence and Clinical Pharmacology to Improve Drug Therapy
This popular conference put on every year by the UBC Therapeutics Initiative in collaboration with UBC Continuing Professional Development is designed to provide physicians, pharmacists, and other health professionals with up-to-date, evidence-based, practical information on prescription drug therapy. Although primarily aimed at prescribers (MD’s, NP’s) and pharmacists, this course will appeal to any health professional who wants to learn and think about the scientific evidence behind what we should or should not be doing with prescription drugs.
7.0 Mainpro M1/MOC Section 1 credits will be available. Note that this conference is not supported by industry funding.
Comments from last year:
- “Excellent, thought-provoking, evidence-based content.“
- “Unbiased speakers who strongly believe in practicing evidence-based medicine.“
- “Promotes critical thinking and provides powerful messages that will stick with me.“
- “Probing questions make you examine your beliefs and how you practice.“
- “Always an excellent course.“
Speakers & Topics
What is the Evidence For or Against Using Opioids for Chronic Pain?
Dr. Jason Busse, National Pain Centre, McMaster University; Chair, Canadian Opioid Guideline Update; Author of forthcoming systematic review on opioids for chronic pain. Hamilton, ON
Dogma vs. Evidence in Management of Atrial Fibrillation and Treatments to Prevent Atherosclerotic Events
Dr. John Mandrola, Cardiac electrophysiologist, endurance athlete, and chief cardiology correspondent for Medscape. Louisville, KY
Is Evidence Available to Guide Palliative Care? and When is it Reasonable to Use an Antipsychotic for People with Dementia?
Dr. Staci Mandrola, Internist, hospice/palliative care physician, and cyclist. Louisville, KY
Guidelines we can trust? Understanding pitfalls, limitations, and conflict of interest in clinical guidelines
Sarah Burgess, PharmD, Dalhousie University
What do we Now Know about the Benefits/Harms of Drugs for Type 2 Diabetes?
Cait O’Sullivan, PharmD, Provincial Academic Detailing Program and UBC Therapeutics Initiative
How can you Tell Whether your Patient is Benefiting from Drug Treatment of COPD?
Aaron Tejani, PharmD, UBC Therapeutics Initiative
Update on Evidence about Blood Pressure Targets and Do Antidepressants Really ‘Work’ for Most Patients?
Dr. James M. Wright, UBC Therapeutics Initiative
- Dealing with difficult chronic pain
- Living with uncertainty or controversy about preventive treatments (statins, ezetimibe, new cholesterol-lowering drugs, diabetes drugs, BP targets, anticoagulants)
- Practical Deprescribing for GP’s,
- Practical Deprescribing for NP’s
- Advanced Practical Deprescribing
Registration now open: http://ubccpd.ca/course/BestEvidence2016